Clinical Trial Update: Study of RH-1 in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

This clinical trial update indicates that the Phase 1 study of RH-1 in patients with advanced solid tumors and Non-Hodgkin's lymphoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma
• Solid Tumor

Drugs mentioned

• RH-1

Snippet

Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: Advanced Solid Tumors, Non-Hodgkin's Lymphoma | Phase 1 | Status: TERMINATED